Need of Dual Antiviral Treatment in Chronic Hepatitis B
1. Abstract 1.1. Introduction: Approximately one third of the world’s population has serological evidence of past or present infection with the hepatitis B virus (HBV). An estimated 350-400 million people are surface HBV antigen (HBsAg) carriers. India has 40 million HBV carriers i.e. 10–15% share of total pool of HBV carriers of the world. In …
Need of Dual Antiviral Treatment in Chronic Hepatitis B Read More »